Crescentic glomerulonephritis during treatment with interferon-alpha 2b.
J M
JM
Durand
F
F
Retornaz
E
E
Cretel
G
G
Kaplanski
J
J
Soubeyrand
D005921:Glomerulonephritis / Q000139:chemically induced*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects* / Q000627:therapeutic use; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000628:therapy; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins
D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins